化合物FLZ通过抑制Src/PTEN/Akt信号通路来减轻神经炎症
Fang-Fang Li1, Yuan-Peng Zheng1, Gen Li1
1State Key Laboratory of Bioactive Substance and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
化合物FLZ通过抑制Src/PTEN/Akt通路,为帕金森病 (PD) 提供神经保护. 这项研究阐明了FLZ的机制,表明它有治疗PD的潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,治疗选择有限.
- 化合物FLZ表现出神经保护作用,但其在PD中的作用机制尚未完全理解.
研究的目的:
- 阐明FLZ在帕金森病中行使神经保护的确切机制.
- 研究PTEN/Akt信号通路在FLZ治疗效果中的作用.
主要方法:
- 利用LPS挑战的BV2细胞来模拟神经炎症.
- 评估了FLZ对PTEN/Akt活性,Src酸化和蛋白质相互作用的影响.
- 研究了FLZ与Src酶的直接结合.
主要成果:
- 在LPS挑战的BV2细胞中,FLZ降低了PTEN/Akt活性.
- FLZ抑制神经炎症取决于PTEN和Src活动.
- FLZ直接结合并抑制Src酶活性,从而减弱Src/PTEN/Akt通路.
结论:
- 在帕金森病中,FLZ通过直接抑制Src. kinase,对神经炎症产生神经保护作用.
- 抑制Src/PTEN/Akt路径是FLZ在PD治疗潜力的关键机制.
- FLZ代表了在帕金森病治疗中临床应用的有前途的治疗剂.
更多相关视频
07:50Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
Published on: July 16, 2012
10:16SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
Published on: January 6, 2017
相关概念视频
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
The Extrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
